The Myocardial Ischemia Reduction with Acute Cholesterol Lowering trial: MIRACuLous or not, it's time to change current practice

<p>Abstract</p> <p>The Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study was the first trial to assess whether statins might be of clinical benefit in those with recently <it>unstable</it> coronary disease. MIRACL found that high-dose ato...

Full description

Bibliographic Details
Main Author: Aronow Herbert D
Format: Article
Language:English
Published: BMC 2002-01-01
Series:Current Controlled Trials in Cardiovascular Medicine
Subjects:
Online Access:http://www.biomedcentral.com/1468-6708/3/3
_version_ 1811317954835382272
author Aronow Herbert D
author_facet Aronow Herbert D
author_sort Aronow Herbert D
collection DOAJ
description <p>Abstract</p> <p>The Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study was the first trial to assess whether statins might be of clinical benefit in those with recently <it>unstable</it> coronary disease. MIRACL found that high-dose atorvastatin was safe and reduced the incidence of the composite endpoint, death, non-fatal myocardial infarction, resuscitated sudden cardiac death or emergent rehospitalization for recurrent ischemia at 16 weeks when compared with placebo. Despite a number of important study limitations, MIRACL's findings and the prior observation that inpatient initiation of lipid-lowering therapy is associated with higher rates of subsequent utilization, suggest that it is prudent to begin statin therapy when patients present with an acute coronary syndrome.</p>
first_indexed 2024-04-13T12:18:37Z
format Article
id doaj.art-8d4c0c30127d4d2ba3f891ff51edc480
institution Directory Open Access Journal
issn 1468-6708
language English
last_indexed 2024-04-13T12:18:37Z
publishDate 2002-01-01
publisher BMC
record_format Article
series Current Controlled Trials in Cardiovascular Medicine
spelling doaj.art-8d4c0c30127d4d2ba3f891ff51edc4802022-12-22T02:47:18ZengBMCCurrent Controlled Trials in Cardiovascular Medicine1468-67082002-01-0131310.1186/1468-6708-3-3The Myocardial Ischemia Reduction with Acute Cholesterol Lowering trial: MIRACuLous or not, it's time to change current practiceAronow Herbert D<p>Abstract</p> <p>The Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) study was the first trial to assess whether statins might be of clinical benefit in those with recently <it>unstable</it> coronary disease. MIRACL found that high-dose atorvastatin was safe and reduced the incidence of the composite endpoint, death, non-fatal myocardial infarction, resuscitated sudden cardiac death or emergent rehospitalization for recurrent ischemia at 16 weeks when compared with placebo. Despite a number of important study limitations, MIRACL's findings and the prior observation that inpatient initiation of lipid-lowering therapy is associated with higher rates of subsequent utilization, suggest that it is prudent to begin statin therapy when patients present with an acute coronary syndrome.</p>http://www.biomedcentral.com/1468-6708/3/3myocardial infarctionunstable anginaHMG-CoAreductase inhibitorsmyocardial ischemia
spellingShingle Aronow Herbert D
The Myocardial Ischemia Reduction with Acute Cholesterol Lowering trial: MIRACuLous or not, it's time to change current practice
Current Controlled Trials in Cardiovascular Medicine
myocardial infarction
unstable angina
HMG-CoA
reductase inhibitors
myocardial ischemia
title The Myocardial Ischemia Reduction with Acute Cholesterol Lowering trial: MIRACuLous or not, it's time to change current practice
title_full The Myocardial Ischemia Reduction with Acute Cholesterol Lowering trial: MIRACuLous or not, it's time to change current practice
title_fullStr The Myocardial Ischemia Reduction with Acute Cholesterol Lowering trial: MIRACuLous or not, it's time to change current practice
title_full_unstemmed The Myocardial Ischemia Reduction with Acute Cholesterol Lowering trial: MIRACuLous or not, it's time to change current practice
title_short The Myocardial Ischemia Reduction with Acute Cholesterol Lowering trial: MIRACuLous or not, it's time to change current practice
title_sort myocardial ischemia reduction with acute cholesterol lowering trial miraculous or not it s time to change current practice
topic myocardial infarction
unstable angina
HMG-CoA
reductase inhibitors
myocardial ischemia
url http://www.biomedcentral.com/1468-6708/3/3
work_keys_str_mv AT aronowherbertd themyocardialischemiareductionwithacutecholesterolloweringtrialmiraculousornotitstimetochangecurrentpractice
AT aronowherbertd myocardialischemiareductionwithacutecholesterolloweringtrialmiraculousornotitstimetochangecurrentpractice